American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med, 2005; 171(4):388–416.
2.
LeJ, AshleyED, NeuhauserMM, BrownJ, GentryC, KlepserME, et al. Consensus summary of aerosolized antimicrobial agents: application of guideline criteria. Pharmacotherapy, 2010; 30(6):562–584.
3.
WoodGC. Aerosolized antibiotics for treating hospital-acquired and ventilator-associated pneumonia. Expert Rev Anti Infect Ther, 2011; 9(11):993–1000.
4.
ValachisA, SamonisG, KofteridisDP. The role of aerosolized colistin in the treatment of ventilator-associated pneumonia: a systematic review and metaanalysis. Crit Care Med, 2015; 43(3):527–533.
5.
Solé-LleonartC, RoubyJJ, ChastreJ, PoulakouG, PalmerL, BlotS, et al. Intratracheal administration of antimicrobial agents in mechanically ventilated adults: an international survey on delivery practices and safety. Respir Care, 2016; 61(8):1008–1014.
6.
Inhaled amikacin solution BAY41-6551 as adjunctive therapy in the treatment of Gram-negative pneumonia (INHALE 1). http://clinicaltrials.gov/show/NCT01799993 Accessed June 3, 2016.
7.
Inhaled amikacin solution BAY41-6551 as adjunctive therapy in the treatment of Gram-negative pneumonia (INHALE 2). http://clinicaltrials.gov/show/NCT00805168 Accessed June 3, 2016.
